Paper8239596
Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen.
Hobden JA and 3 others. Antimicrob Agents Chemother, 1993. Cited by 18 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen. Papers, record 8239596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8239596
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aging | Major topic |
| Ciprofloxacin | Major topic |
| Flurbiprofen | Major topic |
| Keratitis | Major topic |
| Prednisolone | Major topic |
| Pseudomonas Infections | Major topic |
| Animals | |
| Aqueous Humor | |
| Biological Assay | |
| Cornea | |
| Drug Therapy, Combination | |
| Leukocyte Count | |
| Neutrophils | |
| Photic Stimulation | |
| Rabbits | |
| Treatment Outcome |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| EY02377 | NEI NIH HHS | United States | P30EY002377 | PubMed and NIH | NIH RePORTER |
| EY08871 | NEI NIH HHS | United States | R01EY008871 | PubMed and NIH | NIH RePORTER |
| P50EY002377 | NIH | NIH RePORTER |
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 169,202 | Rabbit corneal damage produced by Pseudomonas aeruginosa infection. | Infect Immun | 1975 | https://conductscience.org/library/papers/169202 | PubMed |
| 2 | 8,491,548 | Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases. | Invest Ophthalmol Vis Sci | 1993 | https://conductscience.org/library/papers/8491548 | PubMed |
| 3 | 3,305,411 | Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections. | Invest Ophthalmol Vis Sci | 1987 | https://conductscience.org/library/papers/3305411 | PubMed |
| 4 | 3,124,801 | Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit. | Arch Ophthalmol | 1988 | https://conductscience.org/library/papers/3124801 | PubMed |
| 5 | 3,360,329 | Atypical presentation of geriatric infections. | Geriatrics | 1988 | https://conductscience.org/library/papers/3360329 | PubMed |
| 6 | 2,335,110 | Aging alters the phagocytic capability of inflammatory cells induced into cornea. | Curr Eye Res | 1990 | https://conductscience.org/library/papers/2335110 | PubMed |
| 7 | 2,369,336 | Topical anti-inflammatory agents in an animal model of microbial keratitis. | Arch Ophthalmol | 1990 | https://conductscience.org/library/papers/2369336 | PubMed |
| 8 | 2,210,988 | Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis. | Invest Ophthalmol Vis Sci | 1990 | https://conductscience.org/library/papers/2210988 | PubMed |
| 9 | 2,012,549 | Fulminant pseudomonal keratitis and scleritis in human immunodeficiency virus-infected patients. | Arch Ophthalmol | 1991 | https://conductscience.org/library/papers/2012549 | PubMed |
| 10 | 2,093,970 | Altered immune status in the elderly. | Semin Respir Infect | 1990 | https://conductscience.org/library/papers/2093970 | PubMed |
| 11 | 2,095,322 | The role of pneumolysin in ocular infections with Streptococcus pneumoniae. | Curr Eye Res | 1990 | https://conductscience.org/library/papers/2095322 | PubMed |
| 12 | 1,675,942 | Cell mediated immunity in ageing. | Comp Biochem Physiol A Comp Physiol | 1991 | https://conductscience.org/library/papers/1675942 | PubMed |
| 13 | 1,587,148 | Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis. | Curr Eye Res | 1992 | https://conductscience.org/library/papers/1587148 | PubMed |
| 14 | 1,424,667 | Anti-inflammatory therapy and outcome in a guinea pig model of Pseudomonas keratitis. | Cornea | 1992 | https://conductscience.org/library/papers/1424667 | PubMed |
| 15 | 6,303,695 | Quantification of ocular inflammation: evaluation of polymorphonuclear leucocyte infiltration by measuring myeloperoxidase activity. | Curr Eye Res | 1982 | https://conductscience.org/library/papers/6303695 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,255,611 | Corneal cross-linking guards against infectious keratitis: an experimental model. | Int Ophthalmol | 2023 | https://conductscience.org/library/papers/36255611 | PubMed |
| 23,496,928 | Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis. | BMC Ophthalmol | 2013 | https://conductscience.org/library/papers/23496928 | PubMed |
| 23,365,719 | Infectious keratitis: secreted bacterial proteins that mediate corneal damage. | J Ophthalmol | 2013 | https://conductscience.org/library/papers/23365719 | PubMed |
| 21,987,582 | Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). | Arch Ophthalmol | 2012 | https://conductscience.org/library/papers/21987582 | PubMed |
| 21,121,810 | Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis. | Curr Eye Res | 2010 | https://conductscience.org/library/papers/21121810 | PubMed |
| 21,051,708 | The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis. | Invest Ophthalmol Vis Sci | 2011 | https://conductscience.org/library/papers/21051708 | PubMed |
| 18,385,946 | Changing trends in the clinical course and outcome of bacterial keratitis at King Khaled Eye Specialist Hospital. | Int Ophthalmol | 2009 | https://conductscience.org/library/papers/18385946 | PubMed |
| 11,888,357 | Corneal ulceration in pediatric patients: a brief overview of progress in topical treatment. | Paediatr Drugs | 2002 | https://conductscience.org/library/papers/11888357 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8239596
GET https://conductscience.org/api/papers/v1/8239596/authors